The FDA has halted U.S. enrollment for Newron Pharmaceuticals’ phase 3 schizophrenia trial, following the death of a patient ...
GlobalData on MSN
Patient death puts Newron’s late-stage schizophrenia trial on ice
An independent international safety monitoring board has given the ENIGMA-TRS 1 trial the go-ahead to continue as planned.
New epidemiological research is challenging the long-held assumption that myocardial infarction is the primary cause of ...
Greater Cincinnati is remembering the legacy of longtime Local 12 medical reporter Liz Bonis. Bonis, who was also a ...
No one’ is asking GPs to be ‘100% sure’ of a patient’s cause of death when signing a death certificate, a medical examiner ...
Non-tobacco nicotine use before a positive pregnancy result increased the risk for pregnancy and delivery complications, ...
Liz Bonis, longtime Cincinnati medical reporter, has died after battling colon cancer, Local12 confirmed Thursday.
After two years of treatment, there was an 87% reduction in death in treated patients compared with those who received ...
Most panelists at the SCAI session said the accumulating data are convincing, and for some, they have led to changes in ...
Erasca (ERAS) stock plummeted 50% following disappointing trial results for ERAS-0015, a patient death, and a patent lawsuit ...
The Food and Drug Administration (FDA) has placed a hold on the enrollment of new patients in the phase 3 ENIGMA-TRS 2 study evaluating evenamide in treatment-resistant schizophre ...
I lost one patient unexpectedly, another predictably and another soon after that. Each time, there were things to do: write ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results